Treatment Algorithms for Inflammatory Myopathies in Adults: from Guidelines to Clinical Practice

Area of Science:

• Rheumatology and Immunology
• Internal Medicine
• Clinical Therapeutics

Background:

• Inflammatory myopathies are complex autoimmune disorders with diverse clinical manifestations.
• Limited clinical trials have impeded the development of robust, evidence-based management strategies.
• Existing treatment guidelines show significant heterogeneity, necessitating a unified approach.

Purpose of the Study:

• To develop consensus-driven treatment guidelines for inflammatory myopathies.
• To provide a pragmatic management approach tailored to distinct clinical and immunological phenotypes.
• To integrate existing guidelines, clinical experience, and recent evidence.

Main Methods:

• Comparative review of published treatment guidelines.
• Synthesis of authors' clinical experience from multidisciplinary meetings.
• Inclusion of recent clinical trial and observational study data.

Main Results:

• Significant heterogeneity exists in current therapeutic recommendations for inflammatory myopathies.
• Novel therapies show promise for influencing future treatment decisions.
• A unified therapeutic algorithm remains challenging to establish.

Conclusions:

• Translating current knowledge into clinical practice is crucial for managing inflammatory myopathies.
• A comprehensive approach combining guidelines, experience, and new evidence is proposed.
• Tailored management strategies are essential for addressing disease heterogeneity.